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1. Introduction 
The enzyme glutathione reductase (EC 1.6.4.2.) 
catalyses the reaction between oxidised glutathione 
and NADPH [ 1,2] : 
GSSG + NADPH + H+ w 2 GSH + NADP’ 
The enzyme is a flavoprotein and the catalytic process 
is thought to proceed through single electron transfer 
mediated by the prosthetic group FAD [3]. Glutathione 
reductase is widely distributed in animals, plants and 
bacteria [4-71. The ubiquity of the enzyme seems 
to be related to the requirement of all cells for a high 
level of reduced glutathione, which stabilises cellular 
enzymes and components of cell membranes [8,9]. 
Despite the interest in glutathione reductase as a 
flavin enzyme and its apparent importance to various 
tissues, there is little information on its physical 
properties. This has been mostly due to difficulties 
in purifying sufficient amounts of the enzyme. 
Recently, these difficulties have been overcome for 
the human erythrocyte enzyme [lo]. This species 
yields well-shaped crystals, which have been examined 
by X-rays. They belong to space group C2 with one 
subunit of the molecule in the asymmetric unit. This 
indicates that the two subunits of the molecule are 
identical and related to each other by a two fold axis. 
2. Materials and methods 
The isolation procedure of glutathione reductase 
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has been reported earlier [lo]. The method requires 
ten steps with an overall purification of 40 OOO-fold 
and a yield of 36%, providing 40 mg of enzyme from 
40 litres of blood. The specific activity of this material 
was 240 units per mg. The material was homogeneous 
by zone electrophoresis in starch and polyacrylamide 
and by ultracentrifugation. At the final stage of 
purification the enzyme was stored in potassium 
phosphate buffer pH 7.0, I = 0.1, with 0.2 M KCl, 
0.1% (v/v) 2-mercaptoethanol and 1 mM EDTA [IO]. 
The protein could be readily crystallised either 
at low ionic strength by dialysis against deionised 
water, or at high ionic strength by addition of ammonium 
sulphate. For X-ray analytical purposes, we preferred 
high ionic strength because it allows for much better 
control of the crystallization process. 
For crystallization the enzyme solution at 8 mg/ml 
in the above buffer was initially dialyzed against 
1000 volumes of 20% satureated ammonium sulphate. 
A drop (approx. 50 ~1) of the enzyme solution was 
placed on the underside of a siliconised glass cover 
slip, which stood on a plastic well containing 0.5 ml 
of 30% saturated ammonium sulphate. The rim of the 
well had previously been brushed with thin silicone 
oil to provide a seal. Glutathione reductase crystals 
formed over 24 hr at room temperature. For X-ray 
analysis the crystals were transferred to a storage 
solution which contained potassium phosphate 
buffer pH 7.0, I = 0.3, with 1 mM EDTA and 50% 
saturated ammonium sulphate. 
The ‘hanging drop method’, which was applied 
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here, has the advantage that the salt concentration 
is raised gradually, so that only a few, rather large 
crystals will grow. Furthermore, because of gravity, 
the crystals grow on the droplet surface and not 
on a glass surface where they tend to stick even when 
the glass has been siliconised. Thus, there is no 
breakage problem when transferring the crystals to 
the storage solution. 
3. Results and discussion 
A view of the crystals has been shown earlier [lo]. 
They form elongated polyhedra without any apparent 
external symmetry. Crystal dimensions are approxi- 
mately 400 X 150 X 1.50 pm. Due to FAD the crystals 
have a light yellow colour. 
The crystals were examined by X-ray diffraction on 
a precession camera. The diffraction patterns show 
that the molecules have crystallized in space group C2 
with unit cell dimensions a = 12.0 nm, b = 6.3 nm, 
c = 8.5 nm, @ = 58.2”. The crystals are mechanically 
stable and they are rather stable in the X-ray beam. 
They diffract to a resolution higher than 0.25 nm. A 
precession photograph of the hOl-plane is shown in 
fig.1. 
F’hysico-chemical studies [ 1 l] of human erythrocyte 
Fig.1. X-ray precession photograph of the hOl-plane of a 
glutathione reductase crystal irradiated with nickel-filtered 
Cu K, radiation. The precession angle was 9”. 
glutathione reductase have shown that it is a dimer of 
mol. wt 100 000, consisting of two, probably identical 
subunits. With this information one can determine the 
number of molecules in the asymmetric unit of the 
crystals, and thus assess the magnitude of the problems 
posed in an X-ray structure analysis. For this purpose 
we measured the crystal density by sedimentation of 
crystals in a calibrated toluene-carbontetrachloride 
density gradient. It can be derived [ 121 from crystal 
density (1.25 f 0.02 gcme3), storage solution density 
(1 .12 g-cmw3), protein density (assumed as 1.35 gcmm3), 
and mol. wt (100 000) that there are 0.47 + 0.06 mole- 
cules in the asymmetric unit. This indicates that there 
is half a molecule in the asymmetricunit, the small 
deviation from 0.50 pointing to a mol. wt slightly less 
than 100 000. The result is corroborated by the fact 
that the corresponding crystal volume per molecule 
mass of V, = 0.0029 nm3/dalton fits well into the 
range found with other protein crystals [ 131. 
Since there is one monomer in the asymmetric 
unit, the monomers in the molecule must be related 
to each other by crystallographic symmetry, implying 
that they are exactly identical. Furthermore, these 
findings indicate that the subunits in solution are 
related to each other by a two-fold axis. 
For X-ray analysis it is crucial to prepare heavy 
atom derivatives of the crystalline protein. One can 
expect that the thiol groups present in glutathione 
reductase will be suitable for this purpose. Therefore, 
we soaked the crystals in storage solution containing 
500 PM methyl mercury nitrate for half a day. The 
resulting crystals showed marked changes in the 
reflection intensity pattern, indicating that the methyl 
mercury group has been attached to the protein, pro- 
bably to thiols. Furthermore, the crystals are still well 
ordered and rather stable in the X-ray beam. Thus, we 
expect the methyl mercury nitrate derivative to be 
useful for structural analysis. 
It has been shown that glutathione reductase con- 
tains two classes of free thiols [ 111. One class is 
involved in the association of the enzyme to higher 
aggregates by formation of intermolecular disulphide 
bridges. Since these aggregates are still active, this 
class of thiols is distinct from the other one which 
comprises the thiols in the active centre [I 11. It is 
hoped that heavy atom compounds, for instance 
bulky mercury compounds, can be attached selectively 
to one or the other class, thus providing further 
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crystallographicallydistinct heavy atom derivatives 
of the crystalline protein. 
In conclusion we can state that the crystals seem 
to be amenable to an X-ray analysis of the molecular 
structure. Of particular interest would be the location 
of the FAD moiety, its interaction with NADPH and 
the location of the neighbouring thiols which take 
part in the reactions with oxidised glutathione [3]. 
Furthermore, it would be interesting to see whether 
or not the topology of the glutathione reductase 
polypeptide chain corresponds to those of other 
nucleotide binding proteins [14-17,18,19], thus 
providing essential additional information on the 
structural correspondence within this group of proteins. 
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